Biokinetics and dosimetry of (18)F‐PSMA‐1007 in patients with prostate cancer

PURPOSE: Positron emission tomography‐computed tomography (PET‐CT) using prostate‐specific membrane antigen (PSMA) ligands is a method for imaging prostate cancer. A recent tracer, (18)F‐PSMA‐1007, offers advantages concerning production and biokinetics compared to the standard tracer ((68)Ga‐PSMA‐1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hvittfeldt, Erland, Bjöersdorff, Mimmi, Brolin, Gustav, Minarik, David, Svegborn, Sigrid L., Oddstig, Jenny, Trägårdh, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826386/
https://www.ncbi.nlm.nih.gov/pubmed/36039853
http://dx.doi.org/10.1111/cpf.12785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826386/
https://www.ncbi.nlm.nih.gov/pubmed/36039853
http://dx.doi.org/10.1111/cpf.12785

Ejemplares similares